Dividendos de C.I. MedicalLtd

Dividendo controles de criterios 0/6

C.I. MedicalLtd es una empresa que paga dividendos con una rentabilidad actual de 0.63%.

Información clave

0.6%

Rentabilidad por dividendo

12%

Ratio de pago

Rentabilidad media de la industria	2.2%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	JP¥208.20
Rentabilidad por dividendo prevista a 3 años	0.9%

Últimas actualizaciones de dividendos

Recent updates

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20

The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On

Jul 07

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: 3540 no paga un dividendo notable para el mercado JP, por lo que no es necesario comprobar si los pagos son estables.

Dividendo creciente: 3540 no paga un dividendo notable para el mercado JP, por lo que no es necesario comprobar si los pagos aumentan.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de C.I. MedicalLtd vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de 3540 con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (3540)	0.6%
Suelo de mercado 25% (JP)	1.6%
Techo de mercado 25% (JP)	3.2%
Media de la industria (Healthcare)	2.2%
Previsión de analistas en 3 años (3540)	0.9%

Dividendo destacado: El dividendo de 3540(0.63%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado JP (1.62%).

Alto dividendo: El (0.63%) del dividendo de 3540 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado JP (3.29%).

Pago de beneficios a los accionistas

Cobertura de los beneficios: 3540 no paga un dividendo notable para el mercado JP.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: 3540 está pagando dividendo pero la empresa no tiene flujos de caja libre.

Dividendos de C.I. MedicalLtd

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Upcoming dividend of JP¥28.50 per share

Upcoming Dividend of JP¥15.00 Per Share

Recent updates

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: JP¥51.29 (vs JP¥57.01 in 3Q 2022)

C.I. Medical Co.,Ltd. to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥70.50 (vs JP¥65.91 in 2Q 2022)

C.I. Medical Co.,Ltd. to Report Q2, 2023 Results on Aug 08, 2023

First quarter 2023 earnings released: EPS: JP¥52.10 (vs JP¥86.91 in 1Q 2022)

Full year 2022 earnings: EPS misses analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 16%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

C.I. Medical Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥28.50 per share

Third quarter 2022 earnings released: EPS: JP¥57.01 (vs JP¥65.91 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥56.99 (vs JP¥65.91 in 3Q 2021)

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Naiki Shiken Ltd. from Yuichi Naiki and Yuriko Naiki.

C.I. Medical Co.,Ltd. to Report Q3, 2022 Results on Nov 08, 2022

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Sakura Dental Laboratory from Akira Ochi and Katsumi Ochi.

Second quarter 2022 earnings released: EPS: JP¥65.90 (vs JP¥67.61 in 2Q 2021)

C.I. Medical Co.,Ltd. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to JP¥4,300

C.I. Medical Co.,Ltd. to Report Q1, 2022 Results on May 10, 2022

Investor sentiment improved over the past week

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 24, 2022

Full year 2021 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased to JP¥5,300

Third quarter 2021 earnings released: EPS JP¥65.89 (vs JP¥81.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥67.61 (vs JP¥65.10 in 2Q 2020)

Investor sentiment deteriorated over the past week

Looop Inc. agreed to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. and Yotsuba Electric Power Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥87.40 (vs JP¥48.50 in 1Q 2020)

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Investor sentiment improved over the past week

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

New 90-day low: JP¥5,490

Analysts increase EPS estimates to JP¥320

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

C.I. Medical Co.,Ltd. (JASDAQ:3540) acquired 22.4% stake in Fuji Dental Lab Co., Ltd.

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Revenue and earnings beat expectations

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Yosuke Oda Kaki and Keisuke Hori agreed to acquire an additional 60% stake in One Recto Holdings Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

New 90-day low: JP¥5,900

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

C.I. Medical Co.,Ltd. to Report Fiscal Year 2020 Results on Feb 21, 2021

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Upcoming Dividend of JP¥15.00 Per Share

New 90-day low: JP¥6,150

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

New 90-day low: JP¥6,520

Analysts increase EPS estimates to JP¥251

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Third quarter 2020 earnings released: EPS JP¥81.10

Revenue and earnings beat expectations

C.I. Medical Co.,Ltd. (JASDAQ:3540) reached an agreement to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. from Takashi Kakuya, Chairman and Director of Niigata Prefectural Electric Power Co., Ltd.

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS JP¥81.10

New 90-day high: JP¥8,810

C.I. Medical Co.,Ltd. to Report Q3, 2020 Results on Nov 10, 2020

New 90-day high - JP¥7,770

New 90-day high - JP¥5,630